Arteris, Inc. (NASDAQ:AIP) CFO Sells $51,145.76 in Stock

Arteris, Inc. (NASDAQ:AIP) CFO Nicholas B. Hawkins sold 5,968 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $8.57, for a total transaction of $51,145.76. Following the completion of the transaction, the chief financial officer now owns 186,123 shares of the company’s stock, valued at approximately $1,595,074.11. This represents a 3.11 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Arteris Price Performance

Shares of NASDAQ AIP traded down $0.11 during trading on Tuesday, hitting $8.20. The company had a trading volume of 378,108 shares, compared to its average volume of 311,920. The firm has a market capitalization of $335.77 million, a price-to-earnings ratio of -9.43 and a beta of 1.18. The stock has a fifty day simple moving average of $10.42 and a two-hundred day simple moving average of $8.83. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.30. Arteris, Inc. has a fifty-two week low of $5.76 and a fifty-two week high of $12.64.

Arteris (NASDAQ:AIP) last posted its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.08). Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. The firm had revenue of $15.49 million during the quarter, compared to analyst estimates of $15.34 million. On average, research analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AIP has been the topic of a number of analyst reports. Northland Securities raised their target price on Arteris from $14.00 to $16.00 and gave the company an “outperform” rating in a research report on Wednesday, February 19th. Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price target on shares of Arteris in a research report on Tuesday, February 18th.

Institutional Investors Weigh In On Arteris

A number of hedge funds have recently modified their holdings of AIP. Needham Investment Management LLC increased its stake in shares of Arteris by 14.7% in the 3rd quarter. Needham Investment Management LLC now owns 2,735,000 shares of the company’s stock worth $21,114,000 after acquiring an additional 350,000 shares during the last quarter. G2 Investment Partners Management LLC acquired a new stake in Arteris during the fourth quarter worth about $2,799,000. Federated Hermes Inc. raised its stake in Arteris by 729.4% during the fourth quarter. Federated Hermes Inc. now owns 165,878 shares of the company’s stock worth $1,690,000 after purchasing an additional 145,878 shares during the period. Arrowstreet Capital Limited Partnership acquired a new position in Arteris in the 4th quarter valued at about $1,272,000. Finally, EAM Investors LLC acquired a new stake in shares of Arteris during the 4th quarter worth about $983,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.